STOCK TITAN

UnitedHealth (UNH) director adds 50 shares via dividend equivalents grant

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

UNITEDHEALTH GROUP INC director Frederick William McNabb III received a grant tied to existing deferred stock units. On this Form 4, he acquired 50 shares of Common Stock at a price of $0.00 per share as dividend equivalents on vested deferred stock units. After this award, he directly holds 15,212 shares of UnitedHealth Group common stock. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.

Positive

  • None.

Negative

  • None.
Insider MCNABB FREDERICK WILLIAM III
Role null
Type Security Shares Price Value
Grant/Award Common Stock 50 $0.00 --
Holdings After Transaction: Common Stock — 15,212 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Shares acquired 50 shares Dividend equivalents grant on vested deferred stock units
Price per share $0.00 per share Grant/award acquisition on June 23, 2026
Post-transaction holdings 15,212 shares Common Stock directly held after the transaction
Transaction code A Grant, award, or other acquisition of Common Stock
Transaction direction acquire Non-derivative acquisition reported in Form 4
dividend equivalents financial
"Represents dividend equivalents paid on vested deferred stock units."
Payments tied to employee or contractor equity awards that mirror the cash dividends paid on the company’s stock; they give the holder the same economic benefit as owning the shares without transferring actual shares—often paid in cash or additional award units when the award becomes payable. Investors care because these payments affect a company’s compensation costs, cash flow and potential share dilution, and they signal how management is being rewarded and aligned with shareholders.
vested deferred stock units financial
"Represents dividend equivalents paid on vested deferred stock units."
Grant, award, or other acquisition regulatory
"transaction_code_description": "Grant, award, or other acquisition""
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MCNABB FREDERICK WILLIAM III

(Last)(First)(Middle)
C/O UNITEDHEALTH GROUP INCORPORATED
1 HEALTH DRIVE

(Street)
EDEN PRAIRIE MINNESOTA 55344

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/23/2026A50(1)A$015,212D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
Remarks:
Faraz A. Choudhry, Attorney-in-Fact for Frederick William McNabb III06/25/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did UNH director Frederick McNabb report?

Director Frederick McNabb reported an acquisition of 50 shares of UNITEDHEALTH GROUP INC common stock. These shares reflect dividend equivalents on vested deferred stock units and were received at $0.00 per share, increasing his direct holdings to 15,212 shares after the transaction.

Was the UNH insider transaction a market purchase or sale?

The UNH insider transaction was not a market purchase or sale. It was coded “A” as a grant or award, reflecting dividend equivalents on vested deferred stock units, issued at $0.00 per share rather than bought or sold on the open market.

How many UNH shares does Frederick McNabb hold after this Form 4?

After this Form 4 transaction, Frederick McNabb holds 15,212 shares of UNITEDHEALTH GROUP INC common stock directly. The filing shows his holdings increased by 50 shares through dividend equivalents paid on vested deferred stock units that are immediately vested under the same terms.

What does “dividend equivalents on vested deferred stock units” mean for UNH?

For UNH, dividend equivalents on vested deferred stock units are additional share credits reflecting dividends on deferred awards. In this filing, 50 shares were credited as immediately vested equivalents, following the same terms as the underlying vested deferred stock units held by the director.

Does the UNH Form 4 show any insider selling activity?

This UNH Form 4 shows no insider selling activity. The transaction summary lists one acquisition and zero dispositions, with 50 shares granted as dividend equivalents and total shares following the transaction reported at 15,212 for director Frederick McNabb.